Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle S Cha

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Journal of Affective Disorders|July 5, 2021
Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic reviewJason Ng, Joshua D Rosenblat, Leanna M W Lui, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 30, 2018
Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severityDanielle S Cha, Nicole Carmona, Rebekah H Cha, et al.
Journal of Affective Disorders|July 2, 2017
Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorderDanielle S Cha, Nicole E Carmona, Mehala Subramaniapillai, et al.
Harvard Review of Psychiatry|September 7, 2018
Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive DisorderRoger S McIntyre, Yena Lee, Nicole E Carmona, et al.
Bipolar Disorders|May 15, 2020
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorderRoger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
Journal of Sleep Research|June 17, 2021
Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2017
Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disordersRodrigo B Mansur, Andre Zugman, Juhie Ahmed, et al.
International Journal of Methods in Psychiatric Research|August 9, 2018
Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteersJohn E Harrison, Harry Barry, Bernhard T Baune, et al.
Psychopharmacology|January 23, 2021
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatmentJason Ng, Leanna M W Lui, Joshua D Rosenblat, et al.
Bipolar Disorders|December 17, 2013
Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorderRoger S McIntyre, Danielle S Cha, Jeanette M Jerrell, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Journal of Affective Disorders|July 5, 2021
Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic reviewJason Ng, Joshua D Rosenblat, Leanna M W Lui, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|October 30, 2018
Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severityDanielle S Cha, Nicole Carmona, Rebekah H Cha, et al.
Journal of Affective Disorders|July 2, 2017
Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorderDanielle S Cha, Nicole E Carmona, Mehala Subramaniapillai, et al.
Harvard Review of Psychiatry|September 7, 2018
Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive DisorderRoger S McIntyre, Yena Lee, Nicole E Carmona, et al.
Bipolar Disorders|May 15, 2020
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorderRoger S McIntyre, Orly Lipsitz, Nelson B Rodrigues, et al.
Journal of Sleep Research|June 17, 2021
Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression?Nelson B Rodrigues, Roger S McIntyre, Orly Lipsitz, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 5, 2017
Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disordersRodrigo B Mansur, Andre Zugman, Juhie Ahmed, et al.
International Journal of Methods in Psychiatric Research|August 9, 2018
Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteersJohn E Harrison, Harry Barry, Bernhard T Baune, et al.
Psychopharmacology|January 23, 2021
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatmentJason Ng, Leanna M W Lui, Joshua D Rosenblat, et al.
Bipolar Disorders|December 17, 2013
Advancing biomarker research: utilizing 'Big Data' approaches for the characterization and prevention of bipolar disorderRoger S McIntyre, Danielle S Cha, Jeanette M Jerrell, et al.
Pageof 8